chr21-46367087-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006031.6(PCNT):​c.3113T>C​(p.Val1038Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.869 in 1,613,630 control chromosomes in the GnomAD database, including 610,688 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.87 ( 57696 hom., cov: 32)
Exomes 𝑓: 0.87 ( 552992 hom. )

Consequence

PCNT
NM_006031.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.194

Publications

46 publications found
Variant links:
Genes affected
PCNT (HGNC:16068): (pericentrin) The protein encoded by this gene binds to calmodulin and is expressed in the centrosome. It is an integral component of the pericentriolar material (PCM). The protein contains a series of coiled-coil domains and a highly conserved PCM targeting motif called the PACT domain near its C-terminus. The protein interacts with the microtubule nucleation component gamma-tubulin and is likely important to normal functioning of the centrosomes, cytoskeleton, and cell-cycle progression. Mutations in this gene cause Seckel syndrome-4 and microcephalic osteodysplastic primordial dwarfism type II. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PCNT Gene-Disease associations (from GenCC):
  • microcephalic osteodysplastic primordial dwarfism type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Moyamoya disease
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.449875E-7).
BP6
Variant 21-46367087-T-C is Benign according to our data. Variant chr21-46367087-T-C is described in ClinVar as Benign. ClinVar VariationId is 159581.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.891 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCNTNM_006031.6 linkc.3113T>C p.Val1038Ala missense_variant Exon 15 of 47 ENST00000359568.10 NP_006022.3 O95613-1
PCNTNM_001315529.2 linkc.2759T>C p.Val920Ala missense_variant Exon 15 of 47 NP_001302458.1 O95613-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCNTENST00000359568.10 linkc.3113T>C p.Val1038Ala missense_variant Exon 15 of 47 1 NM_006031.6 ENSP00000352572.5 O95613-1

Frequencies

GnomAD3 genomes
AF:
0.870
AC:
132358
AN:
152088
Hom.:
57659
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.899
Gnomad AMI
AF:
0.793
Gnomad AMR
AF:
0.838
Gnomad ASJ
AF:
0.876
Gnomad EAS
AF:
0.808
Gnomad SAS
AF:
0.789
Gnomad FIN
AF:
0.842
Gnomad MID
AF:
0.877
Gnomad NFE
AF:
0.876
Gnomad OTH
AF:
0.875
GnomAD2 exomes
AF:
0.853
AC:
212763
AN:
249528
AF XY:
0.850
show subpopulations
Gnomad AFR exome
AF:
0.900
Gnomad AMR exome
AF:
0.834
Gnomad ASJ exome
AF:
0.888
Gnomad EAS exome
AF:
0.816
Gnomad FIN exome
AF:
0.839
Gnomad NFE exome
AF:
0.875
Gnomad OTH exome
AF:
0.870
GnomAD4 exome
AF:
0.869
AC:
1270245
AN:
1461424
Hom.:
552992
Cov.:
64
AF XY:
0.866
AC XY:
629436
AN XY:
726984
show subpopulations
African (AFR)
AF:
0.900
AC:
30128
AN:
33480
American (AMR)
AF:
0.833
AC:
37234
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.889
AC:
23241
AN:
26134
East Asian (EAS)
AF:
0.779
AC:
30914
AN:
39698
South Asian (SAS)
AF:
0.788
AC:
68001
AN:
86256
European-Finnish (FIN)
AF:
0.842
AC:
44603
AN:
52992
Middle Eastern (MID)
AF:
0.836
AC:
4820
AN:
5768
European-Non Finnish (NFE)
AF:
0.880
AC:
978885
AN:
1111980
Other (OTH)
AF:
0.868
AC:
52419
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
10287
20574
30860
41147
51434
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21346
42692
64038
85384
106730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.870
AC:
132453
AN:
152206
Hom.:
57696
Cov.:
32
AF XY:
0.864
AC XY:
64292
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.898
AC:
37338
AN:
41558
American (AMR)
AF:
0.838
AC:
12820
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.876
AC:
3038
AN:
3470
East Asian (EAS)
AF:
0.807
AC:
4158
AN:
5150
South Asian (SAS)
AF:
0.788
AC:
3803
AN:
4824
European-Finnish (FIN)
AF:
0.842
AC:
8922
AN:
10592
Middle Eastern (MID)
AF:
0.878
AC:
258
AN:
294
European-Non Finnish (NFE)
AF:
0.876
AC:
59544
AN:
68004
Other (OTH)
AF:
0.876
AC:
1850
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
890
1780
2671
3561
4451
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
896
1792
2688
3584
4480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.873
Hom.:
164481
Bravo
AF:
0.873
TwinsUK
AF:
0.877
AC:
3253
ALSPAC
AF:
0.883
AC:
3404
ESP6500AA
AF:
0.898
AC:
3958
ESP6500EA
AF:
0.875
AC:
7527
ExAC
AF:
0.852
AC:
103477
Asia WGS
AF:
0.800
AC:
2784
AN:
3478
EpiCase
AF:
0.873
EpiControl
AF:
0.874

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Microcephalic osteodysplastic primordial dwarfism type II Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

May 31, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 22, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.83
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.0040
DANN
Benign
0.35
DEOGEN2
Benign
0.031
T
Eigen
Benign
-2.0
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.055
N
LIST_S2
Benign
0.10
T
MetaRNN
Benign
9.4e-7
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-0.34
N
PhyloP100
-0.19
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.041
Sift
Benign
0.64
T
Sift4G
Benign
0.56
T
Polyphen
0.0
B
Vest4
0.0050
MPC
0.097
ClinPred
0.025
T
GERP RS
-9.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.015
gMVP
0.047
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6518289; hg19: chr21-47787002; COSMIC: COSV64031868; API